Evaluation of prognostic significance in extracapsular spread of pelvic lymph node metastasis in patients with cervical cancer

Background: Extracapsular spread of lymph node (LN) metastasis has been shown as a negative prognostic factor in cancers of several organs. This Study was performed to clarify the prognostic significance of extracapsular spread of pelvic lymph node metastases in patients who underwent radical hysterectomy and pelvic. paraaortic lymphadenectomy for International Federation of Gynecology and Obstetrics (FIGO) Stage I-II cervical carcinoma. Methods: Ninety-five patients were treated with radical hysterectomy and pelvic paraaortic lymphadenectomy for Stage I-II cervical carcinoma. Twenty-one cases with positive node,,; of the tumor and lymph nodes were reviewed. The describtion of the pattern of metastasis present in the node was focused oil: maximal diameter of metastasis was compared with the maximal diameter of the node, the capsular integrity, and the type of immune response. The prognostic significance of extracapsular spread (ECS). maximal diameter of metastasis and the type of immune response of pelvic metastases was evaluated with respect to disease-free survival (DFS), overall survival. and the pattern of disease recurrence. Results: ECS was seen in 52.4% (11/21) of the cases. The 5-year DFS rate in patients with ECS was significantly lower compared to patients without ECS (63.4% vs 100%: p = 0.03). To assess the independent impact of ECS on overall Survival, the multivariate Cox regression model was not significantly different. Conclusion: From data ill Our Study and those obtained from the literature. the occurence of ECS should be given in the pathology report. Including ECS in the classification of nodal involvement might be helpful in better prognostic discrimination of patients with metastatic lymph nodes.

Cervix carcinoma; Pelvic metastasis; Extracapsular spread

[1] Averette H.E., Nguyen H.N., Donato D., Penalver M.A., Sevin B.U., Estape R., Little W.A.: “Radical hysterectomy for early invasive cervical cancer: a 25-year prospective experience with the Miami tecnique”. Cancer, 1993, 71, 1422.

[2] Sevin B.U., Nadji M., Lampe B., Lu Y., Hilsenbeck S., Koechli O., Averette H.E.: “Prognostic factors in early stage cervical carcinoma treated with radical hysterectomy”. Cancer, 76, 1978, 1996.

[3] Sevin B.U., Nadji M., Averette H.E., Hilsenbeck S., Smith D., Lampe B.: “Microinvasive carcinoma of the cervix”. Cancer, 1992, 70, 2121.

[4] Sevin B.U., Method M.W., Nadji M., Lu Y., Avarette H.E.: “Small cell carcinoma of the cervix treated with radical hysterectomy”. Cancer, 1996, 77, 1489.

[5] Singh N., Arif S.: “Histopathologic parameters of prognosis in cervical cancer-a review”. Int. J. Gynecol. Cancer, 2004, 14, 741.

[6] Origoni M., Sideri M., Garsia S., Carinelli S.G., Ferrari A.G.: “Prognostic value of pathologic patterns of lymph node positivity in squamous cell carcinoma of the vulva Stage III and IV A FIGO”. Gynecol. Oncol., 1992, 45, 313.

[7] Johnson J.T., Wagner R.L., Myers E.N.: “A long-term assessment of adjuvant chemotherapy on outcome of patients with extracapsular spread of cervical metastases from squamous carcinoma of the head and neck”. Cancer, 1996, 77, 181.

[8] Donegan W.L., Stine S.B., Samter T.G.: “Implications of extracapsular nodal metastases for treatment and prognosis of breast cancer”. Cancer, 1993, 72, 778.

[9] Morice P., Castaigne D., Pautier P., Rey A., Haie-Meder C., Leblanc M., Duvillard P.: “Interest of para-aortic lymphadenectomy in patients with Stage IB and II cervical carcinoma”. Gynecol. Oncol., 1999, 73, 106.

[10] Samlal R.A.K., van der Velden J., Schilthuis M.S., Gonzalez D.G., Ten Kate F.J., Hart A.A.M., Lammes F.B.: “Identification of highrisk groups among node-positive patients with Stage IB and IIA cervical carcinoma”. Gynecol. Oncol., 1997, 64, 463.

[11] Hale R.J., Buckley C.H., Fox H.,Wilcox F.L., Tindall V.R., Logue J.P.: “The morphology and distribution of lymph node metastases in Stage IB/IIA cervical carcinoma: relationship to prognosis”. Int. J. Gynecol. Cancer, 1991, 1, 233.

[12] Tinga D.J., Timmer P.R., Bouma J., Aalders J.G.: “Prognostic significance of single versus multiple lymph node metastases in cervical carcinoma Stage IB”. Gynecol. Oncol., 1990, 39, 175.

[13] Horn L.C., Hentschel B., Galle D., Bilek K.: “Extracapsular extension of pelvic lymph node metastasese is of prognostic value in carcinoma of the cervix uteri”. Gynecol. Oncol., 2008, 108, 63.

[14] Scully R.E., Bonfiglio T.A., Kurman R.J., Silverberg S.G.,Wilkinson E.J.: “World Health Organization International Histological Classification of Tumours: Histological Typing of Female Genital Tract Tumours”. 2nd edition, Berlin, Springer-Verlag, 13,1994.

[15] Cottier H., Turk J., Sobin L.: “A proposal for a standardized system of reporting human lymph node morphology in relation to immunological function”. Bull. World Health Org., 1972, 47, 375.

[16] van Nagell J.R., Donaldson E.S., Parker J.C., van Dyke A.H., Wood E.G.: “The prognostic significance of pelvic lymph node morphplogy in carcinoma of the uterine cervix”. Cancer, 1977, 39, 2624.

[17] Cheng L., Bergstralh E.J., Cheville J.C., Slezak J., Corica F.A., Zincke H. et al.: “Cancer volume of lymph node metastases predict progression in prostate cancer”. Am. J. Surg. Pathol., 1998, 22, 1491.